Physician profile
Joel A Greenberg
NPI 1518909639
$6,885.63
in general payments reported to CMS, 2019-2025
45 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,934 · 2020: $2,505 · 2021: $1,333 · 2022: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $1,199.30 | 2019-2021 | |
| Biogen, INC. | $512.07 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $492.41 | 2019-2021 | |
| Allergan, INC. | $481.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $431.31 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $429.86 | 2019-2021 | |
| Ucb, INC. | $314.86 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $222.57 | 2020-2021 | |
| Eisai INC. | $216.01 | 2019-2021 | |
| Lundbeck LLC | $188.73 | 2019-2021 | |
| Amgen INC. | $184.57 | 2019-2021 | |
| Abbvie INC. | $180.55 | 2021-2022 | |
| Genentech USA, INC. | $178.55 | 2019-2021 | |
| Acorda Therapeutics, INC | $147.11 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $141.67 | 2019 |
Show all 45 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.